课题基金 / 基金详情

Tim3调控定居巨噬细胞减轻AMI心肌损伤的机制研究

批准号:
82101913
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
魏寅祥
依托单位:
学科分类:
区域免疫及黏膜免疫疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
魏寅祥

项目摘要

结项摘要

相似基金

相关文献

中文摘要
心脏定居巨噬细胞(cardiac resident macrophages, rCMΦ)对急性心梗(AMI)的损伤与修复有至关重要的影响,对其关键调控分子的发现与机制探究具有重要科学意义。我们研究发现:新型免疫检查点分子Tim3过表达小鼠AMI损伤轻微;Tim3敲除及sTim3蛋白阻断处理的小鼠AMI损伤加重;Tim3在MΦ上表达显著高于心肌与内皮细胞。而Tim3调控rCMΦ减轻AMI心肌损伤的机制尚需探究。本项目拟在AMI动物模型中研究:①Tim3在心脏MΦ上的表达特征及对其群体构成的影响;②Tim3对rCMΦ驱动的外周MΦ浸润与极化的影响及其在调控rCMΦ自身增殖、吞噬及细胞因子分泌功能中的作用;③靶向Tim3进行激动剂干预及rCMΦ移植改善AMI损伤的效果。本研究有望发现Tim3在心脏免疫中的新功能,揭示Tim3调控rCMΦ功能减轻AMI损伤的新机制。
英文摘要
Cardiac resident macrophages (rCMΦ) play an important role in the injury and repair during acute myocardial infarction (AMI), but its key regulatory molecules and mechanisms need to be explored. Tim3 is an important immune checkpoint molecule, but its effect on cardiac immune microenvironment after AMI has not been reported. In our previous study, we found for the first time that AMI damage was mild in Tim3 overexpression mice, while AMI was aggravated in mice treated with Tim3 knockout and sTim3 protein block. The expression of Tim3 in MΦ was significantly higher than that in myocardium and endothelial cells. The purpose of this study was to study: 1 The expression characteristics of Tim3 in cardiac MΦ and its effect on the population composition of AMI; 2 The effect of Tim3 on the infiltration and polarization of peripheral MΦ driven by rCMΦ, and its relationship with the regulation of proliferation, phagocytosis and cytokine secretion of rCMΦ. 3 The effect of targeted Tim3 agonist intervention and rCMΦ transplantation to improve AMI injury. This study is expected to discover the physiological function of Tim3 in cardiac immune regulation, reveal the new mechanism of Tim3 regulating rCMΦ function to reduce AMI damage, and provide a new theoretical basis for the prevention and treatment of AMI.
本项目拟在申请人已开展的心脏免疫学研究基础上,对既有的“靶向具有关键调控作用的免疫分子防治缺血性心脏病”这一特色研究思路的延伸和拓展,探索新兴免疫检查点分子Tim3在AMI损伤与修复中的作用。.本项目在基金委的支持下顺利实施,完成既定研究目标,结果表明:①Tim3在损伤心脏中表达升高,且在心脏巨噬细胞上呈高水平表达;②敲除或阻断Tim3信号,会加重心梗损伤,且依赖于rCMΦ作用;③阻断Tim3信号会抑制心脏巨噬细胞AMPK活化并加重线粒体损伤,进而加剧巨噬细胞炎症反应与趋化因子分泌;④AMPK激动剂二甲双胍可逆转由阻断Tim3引起的巨噬细胞炎症与趋化因子分泌并减轻心脏损伤;通过本项目实施,揭示了Tim3在心血管系统中的新作用,初步阐明了Tim3调控rCMΦ减轻AMI损伤的新机制,为AMI防治提供新思路。.此外,在本项目的支持下,申请人还完成了以下研究发现:①在针对Tim3调控巨噬细胞功能调控脑炎的研究中发现Tim3通过MARCH8泛素化MHCII表达水平;②在围绕Tim3调控非免疫细胞炎症反应的研究中发现Tim3调控肾小管上皮细胞NF-kapaB活化影响急性肾损伤;③在中性粒-巨噬细胞互作的研究中发现中性粒胞外诱捕网受TRAIL-DR5调控发挥作用。上述发现,是围绕Tim3在不同疾病中生物学功能及心脏免疫中关键细胞与分子探索两个研究维度进行的拓展与探索,为后续深入理解Tim3和心血管免疫间关系及开展更深一步研究奠定了基础。
国内基金
海外基金